Third Annual Personalized IBD and VEO-IBD: Genomics, Microbiome, Biologics and Beyond

Friday, April 5, 2019, 7:30 AM - 4:30 PM, Children's Hospital of Philadelphia

This one-day course is designed to present the latest developments in research and clinical care for very-early-onset inflammatory bowel disease (VEO-IBD) and pediatric IBD. Participants will receive a comprehensive overview of the genomic, immunologic and microbiome discoveries in VEO-IBD and in pediatric IBD and of the advances in the diagnosis, management and therapy of the disease. This will include lectures by nationally and internationally recognized experts and interactive panel discussions.

This activity has been designed for gastroenterologists, gastrointestinal surgeons, GI fellows and residents, physician assistants, clinical nurse specialists, radiologists, pathologists, nutritionists, and other healthcare professionals.

Nationally Renowned Speakers include:

• Lindsey Albenberg, DO

• Robert Baldassano, MD

• Edward Behrens, MD

• Eric Benchimol, MD, PhD

• Louis Cohen, MD

• Maire Conrad, MD

• Marla Dubinsky, MD

• Andrew Grossman, MD

• Jeffery Hyams, MD

• Judith Kelsen, MD

• Petar Mamula, MD

• Peter Mattei, MD

• Mark Osterman, MD

• David Piccoli, MD

• Joel Rosh, MD

With opening remarks by Joseph St. Geme II, MD and David Piccoli, MD

Attendees are welcome to submit difficult cases to the VEO-IBD and pediatric IBD panel discussions at [email protected]

1. Describe the role of the dysregulated immune system in VEO-IBD and pediatric IBD and how this can impact therapeutic strategies
2. Review the management of difficult cases in VEO-IBD and pediatric IBD
3. Determine appropriate therapy for patients with VEO-IBD and pediatric IBD, considering the both the patients phenotype and underlying genetics
4. Determine the therapeutic targets in pediatric IBD and outcome measures of success of therapy
5. Discuss the management of difficult cases in VEO-IBD and pediatric IBD
6. Discuss the role of surgery in pediatric IBD: how to determine optimal timing for intervention
7. Analyze epidemiologic trends in VEO-IBD and Pediatric IBD
8. Explain how to counsel patients about the role of diet in disease development and as therapy for patients with IBD

The Children's Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician AMA PRA Category 1 Credits™ Attendance (includes PA, RT, RDMS) (6.00 hours)

Friday, April 5, 2019